Published in Mucosal Immunol on July 08, 2015
Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization. PLoS One (2015) 0.81
Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunology (2016) 0.75
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins. Cell Rep (2017) 0.75
Celiac disease. N Engl J Med (2007) 10.98
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol (2002) 6.85
BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (1999) 5.99
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med (2009) 4.71
BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med (2004) 4.41
Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science (2002) 4.21
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 3.53
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology (1998) 3.22
Molecular basis of celiac disease. Annu Rev Immunol (2000) 3.09
Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol (2014) 2.88
Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol (1998) 2.88
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest (2003) 2.87
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol (2010) 2.55
IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol Biol (2012) 2.42
AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology (2006) 1.94
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet (1996) 1.94
In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut (2004) 1.79
pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics (2014) 1.76
Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med (2002) 1.75
Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol (2006) 1.68
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol (2001) 1.65
Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association? Gut (1997) 1.60
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol (2005) 1.58
Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol (2008) 1.55
The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest (2011) 1.53
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut (2006) 1.51
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med (2014) 1.49
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine. J Exp Med (2012) 1.33
Models of somatic hypermutation targeting and substitution based on synonymous mutations from high-throughput immunoglobulin sequencing data. Front Immunol (2013) 1.25
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr (2008) 1.13
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol (2003) 1.13
Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. J Pediatr Gastroenterol Nutr (2008) 1.07
Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses. Mucosal Immunol (2012) 1.07
The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One (2010) 1.05
Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr (2009) 1.01
Long-lived plasma cells from human small intestine biopsies secrete immunoglobulins for many weeks in vitro. J Immunol (2011) 1.00
Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology (2012) 1.00
Dynamics of celiac disease-specific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis (2009) 0.93
A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J Proteome Res (2009) 0.93
Evidence for local expansion of IgA plasma cell precursors in human ileum. J Immunol (2009) 0.91
High density of intraepithelial gammadelta lymphocytes and deposits of immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with IgA deficiency. Clin Exp Immunol (2009) 0.91
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. BMC Immunol (2008) 0.91
Molecular single-cell PCR analysis of rearranged immunoglobulin genes as a tool to determine the clonal composition of normal and malignant human B cells. Methods Mol Biol (2004) 0.84
Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Clin Exp Immunol (2011) 0.84
The human intestinal B-cell response. Mucosal Immunol (2016) 0.76
Associations of coeliac disease with coronary heart disease and cerebrovascular disease: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis (2015) 0.76